|
ZNF518B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64850022521534E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80222503587402E-12 |
| Normal-vs-Stage2 |
1.14899999514861E-08 |
| Normal-vs-Stage3 |
8.356600E-03 |
| Normal-vs-Stage4 |
4.748200E-01 |
| Stage1-vs-Stage2 |
8.849600E-01 |
| Stage1-vs-Stage3 |
1.290830E-01 |
| Stage1-vs-Stage4 |
1.291000E-01 |
| Stage2-vs-Stage3 |
1.400040E-01 |
| Stage2-vs-Stage4 |
1.256970E-01 |
| Stage3-vs-Stage4 |
4.299000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0730974149028E-11 |
| Normal-vs-AfricanAmerican |
2.74440004055521E-09 |
| Normal-vs-Asian |
4.955200E-01 |
| Caucasian-vs-AfricanAmerican |
7.483400E-01 |
| Caucasian-vs-Asian |
1.097030E-01 |
| AfricanAmerican-vs-Asian |
3.557400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34240396576502E-11 |
| Normal-vs-Female |
4.241200E-04 |
| Male-vs-Female |
1.709520E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.06380000258955E-08 |
| Normal-vs-Extreme_Weight |
1.7483792191797E-12 |
| Normal-vs-Obese |
7.70810000050304E-07 |
| Normal-vs-Extreme_Obese |
1.15040000003841E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.007800E-01 |
| Normal_Weight-vs-Obese |
1.929800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.056000E-01 |
| Extreme_Weight-vs-Obese |
9.043800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.266800E-01 |
| Obese-vs-Extreme_Obese |
2.370800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.157780E-01 |
| Normal-vs-Age(41-60Yrs) |
3.09519999630581E-08 |
| Normal-vs-Age(61-80Yrs) |
1.76758607750571E-12 |
| Normal-vs-Age(81-100Yrs) |
1.8974000037808E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.654000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.794200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.506300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.404240E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.099900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.880000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65079061531515E-12 |
| Normal-VS-Type2 PRCC |
2.09929995609315E-09 |
| Normal-VS-KIRP CIMP |
7.496000E-01 |
| Normal-VS-Unclassified PRCC |
2.116800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.439600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.365500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.545800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.194470E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.937800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.883810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99760216648792E-15 |
| Normal-vs-N1 |
8.661800E-01 |
| Normal-vs-N2 |
2.362300E-02 |
| N0-vs-N1 |
1.298700E-03 |
| N0-vs-N2 |
4.804200E-01 |
| N1-vs-N2 |
3.532800E-01 |
|
|
